Skip to main content
Back
Watch Compare

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Data quality: 83%
PACB
Nasdaq Manufacturing Measuring & Analyzing Instruments
$1.34
▼ $0.01 (-0.74%)
Mkt Cap: 412.23 M
Price
$1.37
Mkt Cap
412.23 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -113.92 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-1119.86%
Below sector avg (-53.47%)
ROIC-58.12%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio6.24
Interest Coverage-79.65

Valuation

PE (TTM)
-0.75
Above sector avg (-1.48)
P/B Ratio11.42
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.8 -1.5
P/B 11.4 1.6
ROE % -1119.9 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

6 analysts
Hold
Current
$1.34
+92.8%
Target
$2.58
$1.50
$3.00
$3.00
Forecast
Forward P/E -3.25
Forward EPS -$0.41
Est. Revenue 196.59 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.41
-$0.47 – -$0.24
 196.59 M 7
FY2026 -$0.51
-$0.53 – -$0.47
 174.38 M 7

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.13 -$0.12 +10.8%
Q32025 -$0.14 -$0.12 +15.1%
Q22025 -$0.17 -$0.13 +21.5%
Q12025 -$0.19 -$0.15 +20.5%

ETFs Holding This Stock

ARKG ARKG
1.95% weight
NXTE logo NXTE AXS Green Alpha ETF
0.45% weight
ARKK ARKK
0.41% weight
WDNA WDNA
0.31% weight
MEDX logo MEDX Horizon Kinetics Medical ETF
0.08% weight
GINN logo GINN Goldman Sachs Innovate Equity ETF
0.08% weight
WSMVX WSMVX
0.02% weight
DTSVX DTSVX
0.02% weight
VVICX VVICX
0.02% weight
IRSIX IRSIX
0.02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -546.38 M
ROE -1119.86% ROA -67.10%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -113.92 M
ROIC -58.12% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6.24
Interest Coverage -79.65 Asset Turnover N/A
Working Capital 331.03 M Tangible Book Value -297.81 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.75 Forward P/E N/A
P/B Ratio 11.42 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -27.64%
Market Cap 412.23 M Enterprise Value 355.76 M
Per Share
EPS (Diluted TTM) -1.82 Revenue / Share N/A
FCF / Share -0.38 OCF / Share -0.37
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 20.85%
SBC-Adj. FCF -164.26 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -546.38 M -309.85 M -306.74 M -314.25 M -181.22 M
EPS (Diluted) -1.82 -1.59 -1.21 -1.40 -0.89
Gross Profit 45.78 M 37.28 M 52.78 M 49.04 M 58.86 M
Operating Income -553.86 M -474.31 M -334.47 M -307.20 M -210.44 M
EBITDA — — — — —
R&D Expenses 97.31 M 134.92 M 187.17 M 193.00 M 112.90 M
SG&A Expenses 141.49 M 175.02 M 169.82 M 160.85 M 124.12 M
D&A — — — — —
Interest Expense 6.95 M 13.41 M 14.34 M 14.69 M 12.53 M
Income Tax 318,000.0 316,000.0 -11.42 M -93.65 M -93.65 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 784.08 M 1.26 B 1.75 B 1.77 B 2.01 B
Total Liabilities 778.73 M 753.85 M 1.04 B 1.20 B 1.22 B
Shareholders' Equity 5.35 M 506.59 M 701.30 M 562.90 M 790.99 M
Total Debt — 0.0 490,000.0 898.53 M 896.07 M
Cash & Equivalents 63.71 M 55.37 M 179.91 M 325.09 M 460.73 M
Current Assets 375.05 M 495.68 M 742.05 M 852.07 M 1.10 B
Current Liabilities 72.83 M 66.30 M 95.03 M 263.34 M 71.71 M